Codagenix, Inc. is a pioneering biotech company based in Stony Brook, NY, that is revolutionizing global health through the engineering of viruses. By combining live-attenuated virus design with cutting-edge codon deoptimization technology, Codagenix has developed a powerful synthetic biology-based platform to combat infectious diseases and cancer.
With a focus on delivering timely vaccines, innovative cancer therapies, and improved animal health, Codagenix leverages its proprietary synthetic biology-driven approach to create precise, stable edits in viral genomes. This approach offers the broad immunity benefits of live-attenuated viruses while ensuring unparalleled safety, efficacy, and scalability.
Generated from the website